
Clinical Guidelines


September 18, 2025
Cancer-Induced Nerve Injury Identified as Driver of PD-1 Resistance Across Tumor Types
The ASCO Post

September 18, 2025
CheckMate 77T: Nivolumab Maintains Quality of Life and Reduces Symptom Deterioration in Resectable NSCLC
The ASCO Post


September 18, 2025
Study Finds Insufficient Evidence Demonstrating Clinical Benefit of Multicancer Detection Tests
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.

September 18, 2025
Observation Outperforms Adjuvant Crizotinib for Resected ALK-Positive NSCLC
The ASCO Post


September 17, 2025
Use of Cemiplimab as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma
The ASCO Post

September 17, 2025
This Week’s CGT News: Capsida Pauses Study After Patient Death
The Medicine Maker
Advertisement
Recommendations
Advertisement